Abstract
1 The psychotropic effects of a single oral dose of (--)-tryptophan (5 g) in human volunteers were investigated using a series of physiological and psychological tests. 2 Self-ratings of mood showed increase in drowsiness but no euphoria was detected. 3 Severe initial nausea occurred and headache increased; other bodily symptoms were unaffected. 4 Trptophan caused increased activity in the slow wavebands of the EEG but did not alter the other physiological measures. 5 The levels of total and free tryptophan in the plasma increased 8 and 20 fold respectively to peak levels 2 h after ingestion.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALEXANDER F., CURTIS G. C., 3rd, SPRINCE H., CROSLEY A. P., Jr L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINE. J Nerv Ment Dis. 1963 Aug;137:135–142. doi: 10.1097/00005053-196308000-00004. [DOI] [PubMed] [Google Scholar]
- Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
- Bellet S., Kershbaum A., Finck E. M. Response of free fatty acids to coffee and caffeine. Metabolism. 1968 Aug;17(8):702–707. doi: 10.1016/0026-0495(68)90054-1. [DOI] [PubMed] [Google Scholar]
- Bond A. J., Lader M. H. Residual effects of hypnotics. Psychopharmacologia. 1972;25(2):117–132. doi: 10.1007/BF00423189. [DOI] [PubMed] [Google Scholar]
- Brezinová V., Loudon J., Oswald I. Tryptophan and sleep. Lancet. 1972 Nov 18;2(7786):1086–1087. doi: 10.1016/s0140-6736(72)92372-0. [DOI] [PubMed] [Google Scholar]
- COPPEN A., SHAW D. M., FARRELL J. P. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet. 1963 Jan 12;1(7272):79–81. doi: 10.1016/s0140-6736(63)91084-5. [DOI] [PubMed] [Google Scholar]
- Carroll B. J., Mowbray R. M., Davies B. Sequential comparison of L-tryptophan with E.C.T. in severe depression. Lancet. 1970 May 9;1(7654):967–969. doi: 10.1016/s0140-6736(70)91096-2. [DOI] [PubMed] [Google Scholar]
- Coppen A., Shaw D. M., Herzberg B., Maggs R. Tryptophan in the treatment of depression. Lancet. 1967 Dec 2;2(7527):1178–1180. doi: 10.1016/s0140-6736(67)91894-6. [DOI] [PubMed] [Google Scholar]
- Coppen A., Whybrow P. C., Noguera R., Maggs R., Prange A. J., Jr The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry. 1972 Mar;26(3):234–241. doi: 10.1001/archpsyc.1972.01750210042009. [DOI] [PubMed] [Google Scholar]
- Curzon G. 5-hydroxyindoles and migraine. Adv Pharmacol. 1968;6(Pt B):191–200. doi: 10.1016/s1054-3589(08)60315-4. [DOI] [PubMed] [Google Scholar]
- DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
- Eccleston D., Ashcroft G. W., Crawford T. B. 5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. II. Applications and drug studies. J Neurochem. 1965 Jun;12(6):493–503. doi: 10.1111/j.1471-4159.1965.tb06776.x. [DOI] [PubMed] [Google Scholar]
- Folstein M. F., Luria R. Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med. 1973 Nov;3(4):479–486. doi: 10.1017/s0033291700054283. [DOI] [PubMed] [Google Scholar]
- Glassman A. H., Platman S. R. Potentiation of a monoamine oxidase inhibitor by tryptophan. J Psychiatr Res. 1969 Dec;7(2):83–88. doi: 10.1016/0022-3956(69)90013-2. [DOI] [PubMed] [Google Scholar]
- Grahame-Smith D. G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem. 1971 Jun;18(6):1053–1066. doi: 10.1111/j.1471-4159.1971.tb12034.x. [DOI] [PubMed] [Google Scholar]
- Greenwood M. H., Friedel J., Bond A. J., Curzon G., Lader M. H. The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther. 1974 Sep;16(3):455–464. doi: 10.1002/cpt1974163part1455. [DOI] [PubMed] [Google Scholar]
- Griffiths W. J., Lester B. K., Coulter J. D., Williams H. L. Tryptophan and sleep in young adults. Psychophysiology. 1972 May;9(3):345–356. doi: 10.1111/j.1469-8986.1972.tb03218.x. [DOI] [PubMed] [Google Scholar]
- HODGE J. V., OATES J. A., SJOERDSMA A. REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR. Clin Pharmacol Ther. 1964 Mar-Apr;5:149–155. doi: 10.1002/cpt196452149. [DOI] [PubMed] [Google Scholar]
- Herrington R. N., Bruce A., Johnstone E. C. Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet. 1974 Sep 28;2(7883):731–734. doi: 10.1016/s0140-6736(74)90936-2. [DOI] [PubMed] [Google Scholar]
- Knott P. J., Curzon G. Free tryptophan in plasma and brain tryptophan metabolism. Nature. 1972 Oct 20;239(5373):452–453. doi: 10.1038/239452a0. [DOI] [PubMed] [Google Scholar]
- LAUER J. W., INSKIP W. M., BERNSOHN J., ZELLER E. A. Observations of schizophrenic patients after iproniazid and tryptophan. AMA Arch Neurol Psychiatry. 1958 Jul;80(1):122–130. doi: 10.1001/archneurpsyc.1958.02340070140021. [DOI] [PubMed] [Google Scholar]
- Lader M. H., Tyrer P. J. Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol. 1972 Jul;45(3):557–560. doi: 10.1111/j.1476-5381.1972.tb08113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lipsett D., Madras B. K., Wurtman R. J., Munro H. N. Serum tryptophan level after carbohydrate ingestion: selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acids. Life Sci II. 1973 Jan 22;12(2):57–64. doi: 10.1016/0024-3205(73)90027-1. [DOI] [PubMed] [Google Scholar]
- Marsden C. D., Foley T. H., Owen D. A., McAllister R. G. Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci. 1967 Aug;33(1):53–65. [PubMed] [Google Scholar]
- McMENAMY R. H., ONCLEY J. L. The specific binding of L-tryptophan to serum albumin. J Biol Chem. 1958 Dec;233(6):1436–1447. [PubMed] [Google Scholar]
- Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology. 1971 Mar;10(21):181–191. doi: 10.1016/0028-3908(71)90039-6. [DOI] [PubMed] [Google Scholar]
- OATES J. A., SJOERDSMA A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology. 1960 Dec;10:1076–1078. doi: 10.1212/wnl.10.12.1076. [DOI] [PubMed] [Google Scholar]
- Oswald I., Ashcroft G. W., Berger R. J., Eccleston D., Evans J. I., Thacore V. R. Some experiments in the chemistry of normal sleep. Br J Psychiatry. 1966 Apr;112(485):391–399. doi: 10.1192/bjp.112.485.391. [DOI] [PubMed] [Google Scholar]
- PARE C. M. POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN. Lancet. 1963 Sep 7;2(7306):527–528. doi: 10.1016/s0140-6736(63)90271-x. [DOI] [PubMed] [Google Scholar]
- POLLIN W., CARDON P. V., Jr, KETY S. S. Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science. 1961 Jan 13;133(3446):104–105. doi: 10.1126/science.133.3446.104. [DOI] [PubMed] [Google Scholar]
- SMITH B., PROCKOP D. J. Central-nervous-system effects of ingestin of L-tryptophan by normal subjects. N Engl J Med. 1962 Dec 27;267:1338–1341. doi: 10.1056/NEJM196212272672603. [DOI] [PubMed] [Google Scholar]
- Sakalis G., Curry S. H., Mould G. P., Lader M. H. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):931–946. doi: 10.1002/cpt1972136931. [DOI] [PubMed] [Google Scholar]
- Tizard B. Repetitive auditory stimuli and the development of sleep. Electroencephalogr Clin Neurophysiol. 1966 Feb;20(2):112–121. doi: 10.1016/0013-4694(66)90154-4. [DOI] [PubMed] [Google Scholar]
- Wyatt R. J., Engelman K., Kupfer D. J., Fram D. H., Sjoerdsma A., Snyder F. Effects of L-tryptophan (a natural sedative) on human sleep. Lancet. 1970 Oct 24;2(7678):842–846. doi: 10.1016/s0140-6736(70)92015-5. [DOI] [PubMed] [Google Scholar]
- Wyatt R. J., Kaplan J., Vaughan T. Tolerance and dependence to serotonin. A speculation. Arch Gen Psychiatry. 1973 Nov;29(5):597–599. doi: 10.1001/archpsyc.1973.04200050011002. [DOI] [PubMed] [Google Scholar]